126202002: Levothyroxine sodium (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Substance with molecular messenger mechanism of action (substance)\Hormone\Thyroid hormone\Levothyroxine sodium

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Hormone\Thyroid hormone\Levothyroxine sodium

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

32188019 Levothyroxine sodium en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

730135010 Levothyroxine sodium (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

2638021000005117 Levothyroxinnatrium da Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Danish module (core metadata concept)

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Levothyroxine sodium	Is a	Thyroxine	false	Inferred relationship	Some
Levothyroxine sodium	Is a	Levothyroxine (substance)	false	Inferred relationship	Some
Levothyroxine sodium	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Thyroid hormone (disposition)	true	Inferred relationship	Some
Levothyroxine sodium	This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged.	Levothyroxine (substance)	true	Inferred relationship	Some
Levothyroxine sodium	Is a	Thyroid hormone	true	Inferred relationship	Some
Levothyroxine sodium	Is a	Hormone	false	Inferred relationship	Some
Levothyroxine sodium	Is a	Drug allergen	false	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
levothyroxinnatriumpræparat	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levothyroxine sodium	Inferred relationship	Some
Product containing precisely levothyroxine sodium 25 microgram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levothyroxine sodium	Inferred relationship	Some
Levothyroxine sodium 50 microgram oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levothyroxine sodium	Inferred relationship	Some
Product containing precisely levothyroxine sodium 100 microgram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levothyroxine sodium	Inferred relationship	Some
Product containing precisely levothyroxine sodium 150 microgram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levothyroxine sodium	Inferred relationship	Some
Levothyroxine sodium 175 microgram oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levothyroxine sodium	Inferred relationship	Some
Product containing precisely levothyroxine sodium 200 microgram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levothyroxine sodium	Inferred relationship	Some
Product containing precisely levothyroxine sodium 300 microgram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levothyroxine sodium	Inferred relationship	Some
Levothyroxine sodium 88 microgram oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levothyroxine sodium	Inferred relationship	Some
Product containing precisely levothyroxine sodium 112 microgram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levothyroxine sodium	Inferred relationship	Some
Levothyroxine sodium 137 microgram oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levothyroxine sodium	Inferred relationship	Some
Levothyroxine sodium 250 microgram oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levothyroxine sodium	Inferred relationship	Some
Levothyroxine sodium 0.05mg tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levothyroxine sodium	Inferred relationship	Some
Levothyroxine sodium 0.075mg tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levothyroxine sodium	Inferred relationship	Some
Levothyroxine sodium 0.088mg tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levothyroxine sodium	Inferred relationship	Some
Levothyroxine sodium 0.1mg tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levothyroxine sodium	Inferred relationship	Some
Levothyroxine sodium 0.112mg tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levothyroxine sodium	Inferred relationship	Some
Levothyroxine sodium 0.15mg tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levothyroxine sodium	Inferred relationship	Some
Levothyroxine sodium 0.175mg tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levothyroxine sodium	Inferred relationship	Some
Levothyroxine sodium 0.125mg tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levothyroxine sodium	Inferred relationship	Some
Levothyroxine sodium 0.2mg tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levothyroxine sodium	Inferred relationship	Some
Levothyroxine sodium 0.3mg tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levothyroxine sodium	Inferred relationship	Some
Levothyroxine sodium o.05mg	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levothyroxine sodium	Inferred relationship	Some
Levothyroxine sodium 0.15mg	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levothyroxine sodium	Inferred relationship	Some
Levothyroxine sodium 0.025mg	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levothyroxine sodium	Inferred relationship	Some
Levothyroxine sodium 200mg tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levothyroxine sodium	Inferred relationship	Some
Product containing precisely levothyroxine sodium 125 microgram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levothyroxine sodium	Inferred relationship	Some
Product containing precisely levothyroxine sodium 75 microgram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levothyroxine sodium	Inferred relationship	Some
levothyroxinnatrium 38 µg + liothyroninnatrium 9 µg tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levothyroxine sodium	Inferred relationship	Some
Product containing precisely levothyroxine sodium 100 microgram and liothyronine sodium 25 microgram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levothyroxine sodium	Inferred relationship	Some
Product containing precisely levothyroxine sodium 12.5 microgram and liothyronine sodium 3.1 microgram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levothyroxine sodium	Inferred relationship	Some
Levothyroxine sodium 150 microgram and liothyronine sodium 37.5 microgram oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levothyroxine sodium	Inferred relationship	Some
Product containing precisely levothyroxine sodium 25 microgram and liothyronine sodium 6.25 microgram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levothyroxine sodium	Inferred relationship	Some
Levothyroxine sodium 50 microgram and liothyronine sodium 12.5 microgram oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levothyroxine sodium	Inferred relationship	Some
Liotrix preparation	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levothyroxine sodium	Inferred relationship	Some
levothyroxinnatrium + liothyroninnatrium	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levothyroxine sodium	Inferred relationship	Some
accidentel forgiftning med levotyroxinnatrium	Causative agent	False	Levothyroxine sodium	Inferred relationship	Some	1
tilsigtet forgiftning med levothyroxinnatrium	Causative agent	False	Levothyroxine sodium	Inferred relationship	Some	1
forgiftning med levothyroxinnatrium, uvist med hvilken hensigt	Causative agent	False	Levothyroxine sodium	Inferred relationship	Some	1
forgiftning med natriumlevothyroxin	Causative agent	False	Levothyroxine sodium	Inferred relationship	Some	1
levothyroxinnatrium 25 µg, kapsel	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levothyroxine sodium	Inferred relationship	Some
levothyroxinnatrium 50 µg, kapsel	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levothyroxine sodium	Inferred relationship	Some
levothyroxinnatrium 75 µg, kapsel	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levothyroxine sodium	Inferred relationship	Some
levothyroxinnatrium 100 µg, kapsel	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levothyroxine sodium	Inferred relationship	Some
Levothyroxine sodium 125 microgram oral capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levothyroxine sodium	Inferred relationship	Some
levothyroxinnatrium 150 µg, kapsel	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levothyroxine sodium	Inferred relationship	Some
Product containing levothyroxine sodium in oral dosage form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levothyroxine sodium	Inferred relationship	Some
Product containing precisely levothyroxine sodium 25 microgram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levothyroxine sodium	Inferred relationship	Some	1
Product containing precisely levothyroxine sodium 25 microgram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Levothyroxine sodium	Inferred relationship	Some	1
Levothyroxine sodium 50 microgram oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levothyroxine sodium	Inferred relationship	Some	1
Levothyroxine sodium 50 microgram oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Levothyroxine sodium	Inferred relationship	Some	1
Product containing precisely levothyroxine sodium 100 microgram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levothyroxine sodium	Inferred relationship	Some	1
Product containing precisely levothyroxine sodium 100 microgram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Levothyroxine sodium	Inferred relationship	Some	1
Product containing precisely levothyroxine sodium 150 microgram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levothyroxine sodium	Inferred relationship	Some	1
Product containing precisely levothyroxine sodium 150 microgram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Levothyroxine sodium	Inferred relationship	Some	1
Levothyroxine sodium 175 microgram oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levothyroxine sodium	Inferred relationship	Some	1
Levothyroxine sodium 175 microgram oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Levothyroxine sodium	Inferred relationship	Some	1
Product containing precisely levothyroxine sodium 200 microgram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levothyroxine sodium	Inferred relationship	Some	1
Product containing precisely levothyroxine sodium 200 microgram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Levothyroxine sodium	Inferred relationship	Some	1
Product containing precisely levothyroxine sodium 300 microgram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levothyroxine sodium	Inferred relationship	Some	1
Product containing precisely levothyroxine sodium 300 microgram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Levothyroxine sodium	Inferred relationship	Some	1
Levothyroxine sodium 88 microgram oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levothyroxine sodium	Inferred relationship	Some	1
Levothyroxine sodium 88 microgram oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Levothyroxine sodium	Inferred relationship	Some	1
Product containing precisely levothyroxine sodium 112 microgram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levothyroxine sodium	Inferred relationship	Some	1
Product containing precisely levothyroxine sodium 112 microgram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Levothyroxine sodium	Inferred relationship	Some	1
Levothyroxine sodium 137 microgram oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levothyroxine sodium	Inferred relationship	Some	1
Levothyroxine sodium 137 microgram oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Levothyroxine sodium	Inferred relationship	Some	1
Levothyroxine sodium 250 microgram oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levothyroxine sodium	Inferred relationship	Some	1
Levothyroxine sodium 250 microgram oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Levothyroxine sodium	Inferred relationship	Some	1
Product containing precisely levothyroxine sodium 125 microgram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levothyroxine sodium	Inferred relationship	Some	1
Product containing precisely levothyroxine sodium 125 microgram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Levothyroxine sodium	Inferred relationship	Some	1
Product containing precisely levothyroxine sodium 75 microgram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levothyroxine sodium	Inferred relationship	Some	1
Product containing precisely levothyroxine sodium 75 microgram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Levothyroxine sodium	Inferred relationship	Some	1
Product containing precisely levothyroxine sodium 100 microgram and liothyronine sodium 25 microgram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levothyroxine sodium	Inferred relationship	Some	2
Product containing precisely levothyroxine sodium 100 microgram and liothyronine sodium 25 microgram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Levothyroxine sodium	Inferred relationship	Some	2
Product containing precisely levothyroxine sodium 12.5 microgram and liothyronine sodium 3.1 microgram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Levothyroxine sodium	Inferred relationship	Some	1
Levothyroxine sodium 50 microgram and liothyronine sodium 12.5 microgram oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levothyroxine sodium	Inferred relationship	Some	2
Levothyroxine sodium 50 microgram and liothyronine sodium 12.5 microgram oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Levothyroxine sodium	Inferred relationship	Some	2
levothyroxinnatrium 150 µg, kapsel	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levothyroxine sodium	Inferred relationship	Some	1
levothyroxinnatrium 150 µg, kapsel	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Levothyroxine sodium	Inferred relationship	Some	1
levothyroxinnatrium 75 µg, kapsel	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levothyroxine sodium	Inferred relationship	Some	1
levothyroxinnatrium 75 µg, kapsel	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Levothyroxine sodium	Inferred relationship	Some	1
levothyroxinnatrium 50 µg, kapsel	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levothyroxine sodium	Inferred relationship	Some	1
levothyroxinnatrium 50 µg, kapsel	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Levothyroxine sodium	Inferred relationship	Some	1
levothyroxinnatrium 25 µg, kapsel	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levothyroxine sodium	Inferred relationship	Some	1
levothyroxinnatrium 25 µg, kapsel	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Levothyroxine sodium	Inferred relationship	Some	1
levothyroxinnatrium 100 µg, kapsel	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levothyroxine sodium	Inferred relationship	Some	1
levothyroxinnatrium 100 µg, kapsel	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Levothyroxine sodium	Inferred relationship	Some	1
Levothyroxine sodium 125 microgram oral capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levothyroxine sodium	Inferred relationship	Some	1
Levothyroxine sodium 125 microgram oral capsule	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Levothyroxine sodium	Inferred relationship	Some	1
Product containing precisely levothyroxine sodium 12.5 microgram and liothyronine sodium 3.1 microgram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levothyroxine sodium	Inferred relationship	Some	2
Product containing precisely levothyroxine sodium 12.5 microgram and liothyronine sodium 3.1 microgram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Levothyroxine sodium	Inferred relationship	Some	2
Levothyroxine sodium 150 microgram and liothyronine sodium 37.5 microgram oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levothyroxine sodium	Inferred relationship	Some	2
Levothyroxine sodium 150 microgram and liothyronine sodium 37.5 microgram oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Levothyroxine sodium	Inferred relationship	Some	2
Product containing precisely levothyroxine sodium 25 microgram and liothyronine sodium 6.25 microgram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levothyroxine sodium	Inferred relationship	Some	2
Product containing precisely levothyroxine sodium 25 microgram and liothyronine sodium 6.25 microgram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Levothyroxine sodium	Inferred relationship	Some	2
Levothyroxine sodium 50 microgram and liothyronine sodium 12.5 microgram oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Levothyroxine sodium	Inferred relationship	Some	1
levothyroxinnatrium 38 µg + liothyroninnatrium 9 µg tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levothyroxine sodium	Inferred relationship	Some	2
levothyroxinnatrium 38 µg + liothyroninnatrium 9 µg tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Levothyroxine sodium	Inferred relationship	Some	2
levothyroxinnatrium 75 µg, kapsel	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Levothyroxine sodium	Inferred relationship	Some	1
levothyroxinnatrium 150 µg, kapsel	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Levothyroxine sodium	Inferred relationship	Some	1

Page 1 of 2 End

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
32188019	Levothyroxine sodium	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
730135010	Levothyroxine sodium (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
2638021000005117	Levothyroxinnatrium	da	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	Danish module (core metadata concept)